Kaestner Stefanie, Poetschke Manuela, Roth Christian, Deinsberger Wolfgang
Department of Neurosurgery, Klinikum Kassel, Kassel, Germany.
Applied Statistics, Department 05, University of Kassel, Kassel, Germany.
Neurol Neurochir Pol. 2017 Jan-Feb;51(1):72-76. doi: 10.1016/j.pjnns.2016.11.007. Epub 2016 Nov 30.
Hydrocephalus (HC) occurs due to multiple origins. Time course and dynamic of HC and its therapies differ between underlying pathologies. Different revision rates due to the type of HC are expected. Though hydrocephalus is known to be a life time condition, the lack of shunt malfunction years or decades after initial shunt insertion raises the hope of a superfluous shunt.
We conducted a retrospective survey of our OR-database during a 10 year period. All newly inserted shunt systems and subsequent shunt revisions are recorded according to quantity and time point. All patients were subdivided according their aetiology of HC.
260 patients were eligible with a follow-up of 4.5 years. Subgroups were: 90 patients with NPH, 76 patients with posthaemorrhagic and 16 patients had posttraumatic HC. 22 received a shunt as a consequence of a tumour, 41 were children and 15 for other causes. Overall revision rate was 39.5%. During the first 6 months 55.6%, 57.9% and 75% of patients with NPH, posthaemorrhagic and posttraumatic HC had revisions. In contrast only 38.1% of children and 20% of tumour cases required early revision.
Two different patterns of revision are evident: mainly early revisions in morphologically stable diseases such as posthaemorrhagic, posttraumatic and NPH and predominantly late revisions in changing organisms such as children and tumour patients. The conception HC may be transient because of a lack of late revisions cannot be supported by this data.
脑积水(HC)由多种原因引起。不同潜在病理情况下,脑积水的病程、动态变化及其治疗方法各不相同。预计因脑积水类型不同,翻修率也会有所差异。尽管脑积水是一种终身疾病,但在初次植入分流管数年或数十年后,分流管功能障碍的情况较少,这让人燃起了分流管不再必要的希望。
我们对10年间手术室数据库进行了回顾性调查。根据数量和时间点记录所有新植入的分流系统及其后续的分流管翻修情况。所有患者根据脑积水病因进行分组。
260例患者符合条件,随访时间为4.5年。亚组包括:90例正常压力脑积水患者、76例出血后脑积水患者和16例创伤后脑积水患者。22例因肿瘤植入分流管,41例为儿童,15例因其他原因植入。总体翻修率为39.5%。在最初6个月内,正常压力脑积水、出血后脑积水和创伤后脑积水患者的翻修率分别为55.6%、57.9%和75%。相比之下,只有38.1%的儿童患者和20%的肿瘤患者需要早期翻修。
明显存在两种不同的翻修模式:形态学稳定疾病(如出血后、创伤后和正常压力脑积水)主要是早期翻修,而机体变化的疾病(如儿童和肿瘤患者)主要是晚期翻修。该数据不支持因缺乏晚期翻修而认为脑积水可能是短暂性的这一观点。